9 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07889 | H-58 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | A-549 | Lung Cancer | IC50 = 0.62 ± 0.12 μM |
| dbacp07890 | H-58 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.29 ± 0.08 μM |
| dbacp07891 | H-58 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HepG-2 | Liver Cancer | IC50 = 2.13 ± 0.07 μM |
| dbacp07892 | H-57 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | A-549 | Lung Cancer | IC50 = 0.62 ± 0.12 μM |
| dbacp07893 | H-57 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.29 ± 0.08 μM |
| dbacp07894 | H-57 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HepG-2 | Liver Cancer | IC50 = 2.13 ± 0.07 μM |
| dbacp07895 | H-18 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | A-549 | Lung Cancer | IC50 = 0.89 ± 0.21 μM |
| dbacp07896 | H-18 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.11 ± 0.21 μM |
| dbacp07897 | H-18 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HepG-2 | Liver Cancer | IC50 = 1.61 ± 0.21 μM |